Steven M. Horwitz, MD¹, Owen A. O'Connor, MD^2,3*, Barbara Pro, MD⁴, Tim Illidge, MD, PhD^5*, Swami P. Iyer, MD⁶, Ranjana Advani, MD⁷, Nancy L. Bartlett, MD^8*, Jacob Haaber Christensen^9*, Franck Morschhauser, MD^10*, Eva Domingo-Domenech, MD^11*, Giuseppe Rossi, MD¹², Won Seog Kim, PhD^13*, Tatyana A. Feldman, MD¹⁴, Tobias Menne, MD, PhD^15*, David Belada, MD, PhD^16*, Árpád Illés, MD, PhD^17*, Kensei Tobinai, MD¹⁸, Kunihiro Tsukasaki, MD, PhD¹⁹, Su-Peng Yeh, MD^20*, Andrei R Shustov, MD²¹, Andreas Hüttmann, MD²², Kerry J. Savage, BSc, MD, MSc²³, Sam Yuen, MBBS, FRACP, FRCPA²⁴, Pier Luigi Zinzani, MD²⁵, Harry Miao, MD²⁶, Veronica Bunn, PhD^26*, Keenan Fenton, MA^27*, Michelle A. Fanale, MD²⁸, Markus Puhlmann, MD^27* and Lorenz Truemper, MD, PhD²⁹

¹Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
²E. Couric Cancer Center, University of Virginia, Charlottesville, VA
³TG Therapeutics, New York, NY
⁴Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
⁵Division of Cancer Services, Faculty of Biology,Medicine and Health, University of Manchester, NIHR Biomedical Research Centre, Manchester Academic Health Sciences Centre, Christie Hospital NHS Foundation Trust, Manchester, GBR
⁶MD Anderson Cancer Center/University of Texas, Houston, TX
⁷Stanford Cancer Center, Blood and Marrow Transplant Program, Stanford, CA
⁸Division of Oncology, Washington University School of Medicine in St Louis, St. Louis, MO
⁹Odense University Hospital, Odense, Denmark
¹⁰CHRU de Lille, Lille cedex, Nord-Pas-de-Calais, France
¹¹Institut Catala D'oncologia, L'Hospitalet de Llobregat, Barcelona, Spain
¹²Azienda Ospedaliera Spedali Civili di Brescia, Brescia, Italy
¹³Samsung Medical Center, Seoul, Korea, Republic of (South)
¹⁴Hackensack University Medical Center, Hackensack, NJ
¹⁵Freeman Hospital, Newcastle-upon-Tyne, United Kingdom
¹⁶4th Department of Internal Medicine – Hematology, University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
¹⁷Debreceni Egyetem, Debrecen, Hungary
¹⁸Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
¹⁹Saitama Medical University, International Medical Center, Department of Hematology, Saitama, Japan
²⁰Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan
²¹University of Washington Medical Center, Seattle, WA
²²Universitatsklinikum Essen, Nordrhein-Westfalen, Germany
²³BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
²⁴Calvary Mater Newcastle Hospital, Sydney, Australia
²⁵Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
²⁶Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceuticals Limited, Cambridge, MA
²⁷Seattle Genetics, Inc., Bothell, WA
²⁸Seattle Genetics, Bothell, WA
²⁹Universitätsmedizin Göttingen, Göttingen, Germany

Julio C. Chavez, MD¹, Francine M. Foss, MD², Basem M. William, MD, MRCP³, Jonathan E Brammer, MD⁴, Sonali M. Smith, MD⁵, Anca Prica, MD⁶, Jasmine M. Zain, MD⁷, Joseph M Tuscano, MD⁸, Martha Glenn, MD⁹, Neha Mehta-Shah, MD¹⁰, Ben X Wang^11*, Stephanie Zantinge^11*, Lisa Wang^11*, Ling Zhang, MD^12*, Anmarie Boutrin^13*, Weiguang Zhao^13*, Lily Cheng^14*, Nathan Standifer^15*, Gianluca Carlesso^16*, Jeffrey Moscow^17* and Lillian Siu, MD^11*

¹Moffitt Cancer Center, Tampa, FL
²Hematology, Yale Cancer Center, New Haven, CT
³The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁴The Ohio State University James Comprehensive Cancer Center, Columbus, OH
⁵Comprehensive Cancer Center, University of Chicago, Chicago, IL
⁶Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
⁷City of Hope Comprehensive Cancer Center, Duarte, CA
⁸UC Davis Cancer Center, Sacramento, CA
⁹Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
¹⁰Siteman Cancer Center, Washington University, St. Louis, MO
¹¹Princess Margaret Cancer Centre, Toronto, ON, Canada
¹²Department of Hematopathology, Moffitt Cancer Center, Tampa, FL
¹³US Imaging Hub, Clinical Pharmacology and Safety Sciences, AstraZeneca, Gaithersburg, MD
¹⁴AstraZeneca, Gaithersburg, MD
¹⁵Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, South San Francisco, CA
¹⁶Early Oncology Discovery, Early Oncology R&D, AstraZeneca, Gaithersburg, MD
¹⁷Cancer Therapy Evaluation Program, National Cancer Institute/Investigational Drug Branch, Bethesda, MD

Liudmila Fedorova^*, Kirill Lepik^*, Polina Kotselyabina^*, Elena Kondakova^*, Yuri Zalyalov^*, Evgeniya Borzenkova^*, Vadim Baykov^*, Olga S. Epifanovskaya^*, Elena V. Babenko^*, Ivan S. Moiseev^*, Aleksander Kulagin^*, Natalia Mikhailova^* and Boris Afanasyev^*

RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation

Paul J Bröckelmann, MD^1*, Helen Goergen, Dipl.-Math.^1*, Ulrich Keller^2,3*, Julia Meissner, MD^4*, Karolin Trautmann, MD^5*, Teresa V Halbsguth, MD^6*, Stephanie Sasse, MD^1,7*, Martin Sökler, MD^8*, Andrea Kerkhoff, MD^9*, Stephan Mathas, MD^10*, Andreas Hüttmann, MD¹¹, Matthias Bormann, MD^12*, Andreas Zimmermann, MD^13*, Michael Fuchs^14*, Bastian von Tresckow, MD^15,16*, Christian Baues, MD^17*, Andreas Rosenwald, MD^18*, Wolfram Klapper, MD^19*, Carsten Kobe, MD^20*, Peter Borchmann, MD¹ and Andreas Engert, MD²¹

¹German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Cologne, Germany
²Department of Medicine III, Technical University of Munich, Munich, Germany
³Hematology, Oncology, and Tumor Immunology (Campus Benjamin Franklin), Charité - Universitätsmedizin Berlin, Berlin, Germany
⁴Department of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany
⁵Technische Universität Dresden, University Hospital Carl Gustav Carus, Dresden, Germany
⁶Department of Medicine II, Hematology/Oncology, Goethe University Hospital, Frankfurt/M., Franfkurt, Germany
⁷Clinic for Hematology and Medical Oncology, University Medicine Göttingen, Göttingen, Germany
⁸Innere Medizin II, University Hospital Tübingen, Tübingen, Germany
⁹Department of Medicine A, University Hospital Muenster, Muenster, Germany
¹⁰Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany
¹¹Department of Hematology, University Hospital, Essen, NRW, Germany
¹²Medical Department I, Klinikum Bremen-Mitte, Bremen, Germany
¹³Department of Hematology/Oncology, University Hospital of Munich, LMU Munich, Munich, Germany
¹⁴First department of Internal Medicine / German Hodgkin Study Group (GHSG), Cologne, Germany
¹⁵German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, Center of Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Cologne, Germany
¹⁶Clinic for Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital of Essen, University of Duisburg-Essen, Essen, Germany
¹⁷Faculty of Medicine and University Hospital Cologne, University Hospital Cologne, Department of Radiooncology and Cyberknife Center, Cologne, Germany
¹⁸Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany
¹⁹Department of Hematopathology, University of Schleswig-Holstein, Campus Kiel, Kiel, Germany
²⁰Department of Nuclear Medicine, Faculty of Medicine and University Hospital Cologne, University Hospital of Cologne, Cologne, Germany
²¹Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, Cologne, Germany

Pierluigi Porcu, MD¹, Bradley Haverkos, MD, MPH, MS^2*, Onder Alpdogan, MD^3*, Robert Baiocchi, MD, PhD⁴, Jonathan E Brammer, MD⁵, Tatyana A. Feldman, MD⁶, Marcelo Capra, MD, PhD⁷, Elizabeth A Brem, MD⁸, Phillip Scheinberg, MD⁹, Juliana Pereira, MD, PhD¹⁰, Leyla Shune, MD¹¹, Afton Katkov, MSc^12*, Robert McRae^12*, Lisa Rojkjaer, MD¹³, Ivor Royston, MD¹⁴ and Douglas V. Faller, MD, PhD¹⁵

¹Sidney Kimmel Cancer Center, Dept. of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
²University of Colorado Cancer Center, Aurora, CO
³Department of Medical Oncology, Thomas Jefferson University Hospital, Philadelphia, PA
⁴Ohio State University, Columbus, OH
⁵The Ohio State University James Comprehensive Cancer Center, Columbus, OH
⁶Hackensack University Medical Center, NY, NY
⁷Hospital do Cancer Mae de Deus, Porto Alegre, PB, Brazil
⁸Division of Hematology/Oncology, Dept. of Medicine, UC Irvine Medical Center, Orange, CA
⁹Division of Hematology, Hospital A Beneficência Portuguesa, Sao Paulo, Brazil
¹⁰Division of Hematology, Hospital das Clínicas da Faculdade de Medicina (HCFMUSP), Universidade de Sao Paulo, São Paulo, Brazil
¹¹Division of Hematologic Malignancies and Cellular Therapeutics (HMCT), University of Kansas Medical Center, Kansas City, MO
¹²Viracta Therapeutics, Inc, Cardiff, CA
¹³Viracta Therapeutics, Inc., Cardiff, CA
¹⁴Viracta, Cardiff, CA
¹⁵Boston University School of Medicine, Boston, MA, Boston, MA

Swami P. Iyer, MD¹, Auris Huen, MD^2*, Bradley Haverkos, MD, MPH, MS^3*, Weiyun Z. Ai⁴, Craig Okada, MD, PhD⁵, Timothy M. Kuzel, MD⁶, Mary Jo Lechowicz, MD⁷, Juan Pablo Alderuccio, MD⁸, Ann Mohrbacher, MD⁹, Don A. Stevens, MD¹⁰, Ryan A. Wilcox, MD¹¹, Tatyana A. Feldman, MD¹², Suchitra Sundaram, MD^13*, Deepa Jagadeesh, MD, MPH¹⁴, Nishitha Reddy, MD, MSCI^15*, Kasi Viswanath Routhu, PhD^16*, Prajak Barde, MD^16* and Ajit Mohanchandran Nair, PhD^16*

¹Department of Lymphoma and Myeloma, University of Texas M.D. Anderson Cancer Center, Houston, TX
²The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Colorado Cancer Center, Aurora, CO
⁴Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA
⁵Oregon Health and Science University, Portland, OR
⁶Rush University Medical Center, Chicago, IL
⁷Department of Hematology, Winship Cancer Institute, Atlanta, GA
⁸Sylvester Comprehensive Cancer Center, University of Miami School of Medicine, Miami, FL
⁹Department of Medicine, Division of Hematology, University of Southern California, Keck School of Medicine of USC, Los Angeles, CA
¹⁰Norton Cancer Institute - St Matthews Campus, Louisville, KY
¹¹Rogel Cancer Center, University of Michigan, Ann Arbor, MI
¹²John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹³Roswell Park, Buffalo, NY
¹⁴Taussig Cancer Institute, Department of Hematology and Medical Oncology, Cleveland Clinic, Solon, OH
¹⁵Vanderbilt University Medical Center, Nashville, TN
¹⁶Rhizen Pharmaceuticals S.A., CH-2300 La Chaux-de-Fonds, Switzerland

Ning Dong, MD^1,2, Leidy Isenalumhe, MD¹, Yumeng Zhang, MD^2*, Franco Castillo Tokumori, MD^2*, Todd C. Knepper, PharmD³, Rami Komrokji, MD⁴, Ling Zhang, MD^5*, Haipeng Shao, MD^5* and Lubomir Sokol, MD, PhD¹

¹H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²University of South Florida, Tampa
³Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Moffitt Cancer Center, Tampa, FL
⁵Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL

Guillaume Aussedat^1*, Maryam Idlhaj^2*, Amandine Durand^3*, Xavier Roussel^4*, Pauline Brice, MD^5*, Gilles Salles, MD, PhD⁶, Benedicte Deau Fischer^7*, Adrien Chauchet, MD^8*, Cedric Rossi, MD, PhD^9* and Herve Ghesquieres, MD, PhD^10*

¹Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre-Benite, France
²Hematology department - Centre Hospitalier Lyon Sud, Pierre Benite, France
³Hematology department - CHU Dijon, Dijon, France
⁴Centre Hospitalier Universitaire Besancon, Besancon, FRA
⁵Hopital Saint-Louis, Paris, France
⁶Hematology Department, Memorial Kettering Cancer Center, New York, NY
⁷Hematolgy Department, CHU Cochin, Paris, France
⁸Hematology Department, Besancon University Hospital, Besancon, France
⁹Department of Hematology, CHU Dijon, Dijon, France
¹⁰Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre Benite, France

John Kuruvilla, MD¹, Radhakrishnan Ramchandren², Armando Santoro^3*, Ewa Paszkiewicz-Kozik^4*, Robin Gasiorowski⁵, Nathalie A Johnson, MD, PhD⁶, Laura Maria Fogliatto⁷, Iara Goncalves^8*, José de Oliveira^9*, Valeria Buccheri^10*, Guilherme Fleury Perini^11*, Neta Goldschmidt^12*, Irina Kryachok^13*, Naohiro Sekiguchi^14*, Jianxin Lin^15*, Akash Nahar^15*, Patricia Marinello^15* and Pier Luigi Zinzani, MD¹⁶

¹Princess Margaret Cancer Centre, Toronto, ON, Canada
²The University of Tennessee, Knoxville, TN
³Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
⁴Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland
⁵Concord Repatriation General Hospital, University of Sydney, Sydney, NSW, Australia
⁶Jewish General Hospital, Montreal, QC, Canada
⁷Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil
⁸Fundaçao Pio XII − Hospital de Câncer, São Paulo, Brazil
⁹Casa de Saúde Santa Marcelina, São Paulo, Brazil
¹⁰Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
¹¹Hospital Israelita Albert Einstein, São Paulo, Brazil
¹²Hadassah Medical Center, Jerusalem, Israel
¹³National Cancer Institute, Ukraine, Kiev, Ukraine
¹⁴National Hospital Organization Disaster Medical Center, Tokyo, Japan
¹⁵Merck & Co., Inc., Kenilworth, NJ
¹⁶Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy

David Alejandro Veron, MD¹, Patricia Streitenberger, MD^2*, Cecilia Riccheri, MD^3*, Monica Matus, MD^4*, Pedro Negri Aranguren, MD^5*, Maria Alejandra Costa, MD^6*, Nestor Alfredo Rossi, MD^7*, Elizabeth Hiramatsu, MD^8*, Maria Alejandra Cedola, MD^9*, María Constanza Drozdowski, MD^10*, Sandra Borchichi, MD^11*, Marcelo Coirini, MD^12*, María Cecilia Murray, MD^13*, Karina D'Aloi, MD^14*, Carlos Holmann, MD^15*, Matilde Gomel, MD^16*, Gisela Drago, MD^17*, Horacio Daniel Caferri, MD^18*, Maria Angelica Fernandez Barbieri, MD^19*, Mara Villamil, MD^20*, Claudia Mabel Ruiz, MD^21*, Sandra Ethel Zirone, MD^22* and Monica Makiya, MD^23*

¹GATLA Argentinian Collaborative Group, Pilar, ARG
²GATLA Argentinian Collaborative Group, Buenos Aires, Argentina
³GATLA Argentinian Collaborative Group, El Palomar, ARG
⁴GATLA Argentinian Collaborative Group, Rosario, SL, ARG
⁵GATLA Argentinian Collaborative Group, Paraná, Argentina
⁶GATLA Argentinian Collaborative Group, La Plata, ARG
⁷GATLA Argentinian Collaborative Group, Santa Fe, ARG
⁸GATLA Argentinian Collaborative Group, Córdoba, ARG
⁹GATLA Argentinian Collaborative Group, Neuquén, ARG
¹⁰GATLA Argentinian Collaborative Group, Neuquén, Argentina
¹¹GATLA Argentinian Collaborative Group, Posadas, ARG
¹²GATLA Argentinian Collaborative Group, Rosario, Argentina
¹³GATLA Argentinian Collaborative Group, Mar del Plata, Argentina
¹⁴GATLA Argentininan Collaborative Group, Buenos Aires, ARG
¹⁵GATLA Argentinian Collaborative Group, Córdoba, Argentina
¹⁶GATLA Argentinian Collaborative Group, Resistencia, Argentina
¹⁷GATLA Argentinian Collaborative Group, Mendoza, Argentina
¹⁸GATLA Argentinian Collaborative Group, Bahia Blanca, ARG
¹⁹GATLA Argentinian Collaborative Group, San Isidro, Argentina
²⁰GATLA Argentinian Collaborative Group, San Justo, Argentina
²¹GATLA Argentinian Collaborative Group, La Plata, Argentina
²²GATLA Argentinian Collaborative Group, Rosario, ARG
²³GATLA Argentinian Collaborative Group, Buenos Aires, CH, ARG

Kai Zhu¹, Andrew Jamroz, Bsc^1*, Steven J.T. Huang, BMLSc^2*, Diego Villa, MD MPH³, Ciara L. Freeman, MSc, MBBChir⁴, David W. Scott, MBChB, PhD³, Graham W. Slack, MD⁵, Laurie H. Sehn, MD, MPH⁶, Joseph M. Connors, MD³, Cynthia L. Toze, MD, FRCPC, MSc^3*, Kerry J. Savage, MD MSc³ and Alina S. Gerrie, MD, MPH⁴

¹Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
²Leukemia/BMT Program of BC, Vancouver General Hospital, Vancouver, BC, Canada
³Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and University of British Columbia, Vancouver, BC, Canada
⁴BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
⁵Department of Histopathology, BC Cancer Agency, Vancouver, BC, Canada
⁶Centre for Lymphoid Cancer, Department of Medical Oncology, BC Cancer and The University of British Columbia, Vancouver, BC, Canada

Olivier Tournilhac, MD, PhD^1*, Maya Hacini, MD^2*, Kamal Bouabdallah, MD^3*, Kamel Laribi, MD^4*, Marie Maerevoet, MD^5*, Loic Ysebaert, MD, PhD^6*, Stephanie Guidez^7*, Steven Le Gouill, MD, PhD^8,9, Marc André, MD^10*, Jehan Dupuis, MD^11*, Catherine Thieblemont, MD, PhD¹², Emmanuel Bachy, MD, PhD^13*, Nicolas Daguindau, MD^14*, Franck Morschhauser, MD, PhD^15*, Sabine Tricot, MD^16*, Pierre Feugier, MD, PhD^17*, Anne Banos, MD^18*, Thierry Lamy De La Chapelle, MD, PhD^19*, Adrien Chauchet, MD^20*, Emmanuel Gyan, MD, PhD²¹, Guillaume Cartron, MD, PhD^22*, Hassan Farhat, MD^23*, Vincent Camus^24*, Bernard Drenou, MD, PhD^25*, Hacene Zerazhi, MD^26*, David Sibon, MD, PhD^27*, Emmanuelle Nicolas-Virelizier, MD^28*, Caroline Delette, MD^29*, Sylvia Snauwaert, MD^30*, Nicole Straetmans, MD³¹, Richard Delarue, MD³², Marie Parrens, MD^33*, Céline Bossard, MD^34*, Laurence De Leval, MD³⁵, Philippe Gaulard, MD, PHD^36* and Gandhi Laurent Damaj, MD, PhD³⁷

¹Service d'Hématologie Clinique et Thérapie Cellulaire, CHU, Université Clermont Auvergne EA7453 Chelter CIC-1405, Clermont-Ferrand, FRA
²Hematologie, Centre Hospitalier Metropole Savoie, Chambery, FRA
³Hematology Clinic, University Hospital of Bordeaux, Pessac, France
⁴Department of Hematogy, Centre Hospitalier Le Mans, Le Mans, France
⁵Department of Hematology, Institut Jules Bordet (ULB), Brussels, Belgium
⁶IUCT-Oncopole, Toulouse, France
⁷Service d'Hématologie et de thérapie cellulaire, CHU de Poitiers, Poitiers, France
⁸CRCINA, INSERM, CNRS, Angers University and Nantes University, Nantes, France
⁹Service d'hématologie clinique, CHU de Nantes, Nantes, France
¹⁰Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
¹¹Unité Hémopathies Lymphoïdes, AP-HP Hôpital Henri Mondor, Créteil, France
¹²Hôpital Saint-Louis, Paris, France
¹³Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard, Pierre Bénite, France
¹⁴Hematology Department, CH Annecy Genevois, Annecy, France
¹⁵Clinical Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, France
¹⁶Service d'Hématologie Clinique, CH de Valenciennes, Valenciennes, France
¹⁷Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
¹⁸Hematology department, CH Côte Basque, Bayonne, France
¹⁹Clinical hematology, University Hospital of Rennes, Rennes, France
²⁰Hematology Department, Besancon University Hospital, Besancon, France
²¹Centre Hospitalier Universitaire, Service D'Hemaologie Et Therapie Cellulaire, Tours Cedex, France
²²CHU Montpellier, Department of Clinical Hematology, Montpellier, France
²³Department of Hematology, Hôpital André Mignot, Centre Hospitalier de Versailles, Le Chesnay, France
²⁴Department of Hematology, Centre Henri Becquerel, Rouen, France
²⁵Service d'Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace (GHRMSA), Mulhouse, France
²⁶Clinical Hematology, Avignon Hospital, Avignon, France
²⁷INSERM UMR 1163 & CNRS URL 8254, Hematology Department, Necker University Hospital, APHP, Paris, France, Paris, France
²⁸Centre Leon Berard, Departement d'Oncologie Medicale, Lyon, France
²⁹Oncopole Hopital Sud, Amiens, FRA
³⁰AZ Sint-Jan, Brugge, Belgium
³¹Hopital de Jolimont, Woluwe Saint Lambert, BEL
³²Hematology Department / Hemophilia Center, Necker University Hospital, AP-HP, Paris, France
³³Hôpitaux de Bordeaux CHU, Bordeaux, France
³⁴Département de Pathologie, Centre Hospitalier Universitaire de Nantes, Nantes, France
³⁵Hôpital Universitaire de Lausanne, Lausanne, Switzerland
³⁶Department of Pathology and InsermU955, University Hospital Henri Mondor, Créteil, France
³⁷Institut d'Hématologie de Basse-Normandie, CHU de Caen Normandie, Caen, France

Ilja Kalashnikov, MD^1,2*, Nea Malila, MD, PhD^3*, Sirkku Jyrkkio, MD, PhD^4* and Sirpa Leppa, MD, PhD^1,2,5

¹Faculty of Medicine, University of Helsinki, Research Program Unit, Applied Tumor Genomics Research Program, Helsinki, Finland
²iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
³Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland
⁴Department of Oncology and Radiotherapy, Turku University Hospital, Turku, Finland
⁵Helsinki University Hospital Comprehensive Cancer Centre, Helsinki, Finland

Yuqin Song, MD, PhD^1*, Jun Zhu, BS¹, Ningjing Lin, MD, PhD^1*, Mingzhi Zhang, MD^2*, Hai Bai, MD^3*, Hui Liu, MD^4*, Jie Cui, MD^5*, Xiaoyan Ke, MD^6*, Huilai Zhang, MD, PhD^7*, Lihong Liu, MD^8*, Dongmei Yan, MD^9*, Yongsheng Jiang, MD^10*, Aimin Zang, MD^11*, Junyuan Qi, MD^12*, Li Wang, MD^13*, Zhuogang Liu, MD^14*, Bing Xu, MD, PhD^15*, Ying Zhang, MD^16*, Zhihui Zhang, MD, PhD^17* and Haijin Meng, MD^18*

¹Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, Beijing, China
²First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
³Lanzhou Military Hospital, Lanzhou, China
⁴Department of Hematology, Beijing Hospital, Beijing, China
⁵Gansu Provincial Cancer Hospital, Gansu, China
⁶Hematology and Lymphoma Research Center, Peking University Third Hospital, Beijing, China
⁷Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
⁸The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
⁹Department of hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
¹⁰Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China
¹¹The Affiliate Hospital of Hebei Medical University, Baoding, China
¹²Blood Disease Hospital, Tianjin, China
¹³Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, China
¹⁴Shengjing Hospital of China Medical University, Shenyang, China
¹⁵Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China
¹⁶Affiliated Hospital of Guangdong Medical University, Zhanjiang, China
¹⁷Department of Medical Oncology, Sichuan Cancer Hospital, Chengdu, China
¹⁸Guangzhou Gloria Biosciences Co., Ltd., Beijing, China

Daniela Nasso^1*, Silvia Bolis, MD^2*, Elisabetta Abruzzese, MD ³, Ilaria Romano^4*, Caterina Patti, MD^5*, Nicola Di Renzo, MD^6*, Leonardo Flenghi^7*, Caterina Stelitano, MD^8*, Donato Mannina, MD^9*, Marianna Sassone, MD^10*, Alberto De Stefano^11*, Carlo Chiaramonte^12*, Cristiano Tesei^13*, Ida Provenzano^1* and Maria Cantonetti, MD^14*

¹Hematology Department, Tor Vergata University Hospital, Rome, Italy, Rome, Italy
²Hematology Department, ASST San Gerardo University Hospital, Monza, Italy
³Department of Hematology S. Eugenio Hospital, Rome, Italy, Roma, Italy
⁴SOD di Ematologia- AOU Careggi, florence, Italy
⁵Divisione di Ematologia, Azienda Villa Sofia-Cervello, Palermo, Italy
⁶Hematology and SCT Unit, Vito Fazzi Hospital, Lecce, Italy
⁷Hematology, S. Maria della Misericordia Hospital, Perugia, ITA
⁸Department of Haematology, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy
⁹UOC di Ematologia, Azienda Ospedaliera Papardo, Messina, ITA
¹⁰Lymphoma Unit, Department of Onco-Hematology, IRCCS San Raffaele Scientific Institute, Milan, Italy
¹¹Volontari Per Policlinico Tor Vergata ODV, Rome, Italy
¹²Università degli Studi di Roma "Tor Vergata", Rome, Italy
¹³Fondazione PTV - Policlinico Tor Vergata, UOSD Patologie Linfoproliferative, Rome, Italy
¹⁴1. Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Rome, Italy

Luis E Malpica Castillo, MD¹, Daniel J Enriquez, MD², Denisse A. Castro, MD^3,4, Camila Peña, MD⁵, Henry Idrobo, MD^6*, Lorena Fiad, MD^7*, Maria Prates, MD⁸, Victoria Otero, MD^9*, Mirna Churin, MD^10*, Milagros Altamirano, MD^11*, Gustavo Sandival Ampuero, MD², Ursula Aviles-Perez^12*, Kelly Meza, MD^13*, Laura Aguirre-Martinez, MS^14*, Cristaldo Nancy, MD^15*, Juan L. Maradei, MD^16*, Luciana Guanchiale, MD^17*, Pablo Soto, MD^18*, Jose Luis Viñuela, MD^19*, Maria Elena Cabrera, MD^20*, Sally Rose Paredes, MD^3,21*, Eloisa Riva, MD²², Marcos Di Stefano, MD^23*, Andrea Noboa, MD^24*, Juan Antonio Choque, MD^25*, Myrna Candelaria, MD, PharmD²⁶, Alana Von Glasenapp, MD^27*, Fabiola Valvert, MD²⁸, Marialejandra Torres Viera, MD^29*, Guilherme Fleury Perini, MD^30*, Eduardo Sotomayor, MD³¹, Jorge J. Castillo, MD³², Juan Carlos Ramos, MD, BS³³, Luis Villela Villela, MD, MC^34* and Brady E. Beltrán, MD^3,4*

¹Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
²Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
³Departamento de Oncología y Radioterapia, Hospital Nacional Edgardo Rebagliati Martins, Lima, Peru
⁴Centro de Investigación de Medicina de Precisión, Universidad de San Martin de Porres, Lima, Peru
⁵Hematology Department, Hospital Del Salvador, Santiago, Chile
⁶Hospital Universitario del Valle, Cali, Colombia
⁷Hematología, Hospital Italiano de La Plata, La Plata, Argentina
⁸Hematology, Hospital Italiano La Plata, La Plata, Argentina
⁹Sección Hematología, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
¹⁰Grupo HTLV INBIRS (UBA-CONICET), Universidad de Buenos Aires, Buenos Aires, Argentina
¹¹Medical Oncology Department, Hospital Nacional Guillermo Almenara Irigoyen, Lima, Peru
¹²Universidad Nacional Federico Villareal, Lima, Peru
¹³Department of Pediatrics, Weill Cornell Medicine, New York, NY
¹⁴Facultad de Salud, Universidad del Valle, Cali, Colombia
¹⁵Hospital Italiano de Buenos Aires (HIBA), Buenos Aires, Argentina
¹⁶Servicio de Hematologia, Hospital Municipal Emilio Ferreyra, Necochea, Buenos Aires, Argentina
¹⁷Hospital Privado Universitario de Córdoba, Cordoba, Argentina
¹⁸Hospital Dr. Eduardo Schütz Schroeder, Puerto Montt, Chile
¹⁹Servicio de Hematologia, Hospital Sótero de Rio, Santiago de Chile, Chile
²⁰Hematology Department, Hospital del Salvador, Santiago, Chile
²¹Centro de Investigacion de Medicina de Precision, Universidad de San Martin de Porres, Lima, Peru
²²Cátedra de Hematología, Hospital de Clínicas, Facultad de Medicina, Montevideo, Uruguay
²³Hospital Solón Espinoza Ayala (SOLCA, Quito)/ Universidad San Francisco de Quito (USFQ), Quito, Ecuador
²⁴Servicio de Hematologia, Instituto Oncológico Nacional Dr. Juan Tanca Marengo, Guayaquil, Ecuador
²⁵Servicio de Hematologia, Caja Nacional de Salud - Hospital de Especialidades Materno Infantil La Paz, La Paz, Bolivia (Plurinational State of)
²⁶Research Division, Instituto Nacional de Cancerología, Mexico City, Mexico
²⁷Department of Hematology, Instituto de Prevision Social, Asuncion, Paraguay
²⁸Instituto De Cancerología y Hospital Dr. Bernardo Del Valle (INCAN), Ciudad de Guatemala, Guatemala
²⁹Universidad Central de Venezuela, Caracas, Venezuela (Bolivarian Republic of)
³⁰Hospital Israelita Albert Einstein, Sao Paulo, PA, Brazil
³¹George Washington University Cancer Center, Washington, DC
³²Bing Center for Waldenström Macroglobulinemia, Dana Farber Cancer Institute, Boston, MA
³³Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL
³⁴Internal Medicine division/Hematology and blood bank service, Centro Medico Dr. Ignacio Chavez/ISSSTESON/HermosilloSonora, Hermosillo, Mexico

Vittorio Stefoni, MD, PhD^1*, Paolo Corradini², Lorella Orsucci, MD^3*, Stefano Volpetti^4*, Lisa Argnani^5*, Anna Dodero^6*, Cinzia Pellegrini^7* and Pier Luigi Zinzani, MD⁸

¹Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, Italy
²University of Milano, Department of Oncology and Hemato-Oncology, Istituto Nazionale dei Tumori Fondazione IRCSS, Milano, Italy
³Hematology Division, Città della Salute e della Scienza Hospital, Turin, Italy
⁴Clinica Ematologica, Centro Trapianti e Terapie Cellulari “C. Melzi”, DAME, Università degli Studi, Udine, Italy
⁵Institute of Hematology “L.e A. Seràgnoli”, University of Bologna, Bologna, Italy
⁶Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
⁷Institute of Hematology "L. e A. Seràgnoli", University of Bologna, Bologna, ITA
⁸Institute of Hematology "L. e A. Seràgnoli," University of Bologna, Bologna, Italy

Megan Lee, BS^1*, Molly Schiffer, PharmD^2*, Iris Isufi, MD³, Scott F. Huntington, MD, MPH³, Mina L. Xu, MD^4*, Stuart Seropian, MD³, Lohith Gowda, MD³, Shalin K. Kothari, MD³, Michael Girardi, MD, PhD^5* and Francine M. Foss, MD⁶

¹Yale School of Medicine, New Haven, CT
²Yale-New Haven Hospital, New Haven, CT
³Hematology, Yale University School of Medicine, New Haven, CT
⁴Department of Pathology and Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT
⁵Department of Dermatology, Yale University School of Medicine, New Haven, CT
⁶Hematology, Yale Cancer Center, New Haven, CT

Gustavo Sandival Ampuero, MD¹, Ursula Aviles-Perez^2*, Bryan Valcarcel, MD^3*, Juan C Haro, MD^4*, Daniela Dueñas, MD^1*, Carlos Barrionuevo, MD^1*, Cindy Alcarraz, MD^1*, Sandro Casavilca, MD^1*, Marco Villena, MD^1*, Shirley Quintana, MD^1*, Cesar Samanez-Figari, MD^5*, Luis E Malpica Castillo, MD⁶ and Daniel J Enriquez, MD^1,7

¹Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
²Universidad Nacional Federico Villareal, Lima, Peru
³Milken Institute School of Public Health, The George Washington University, Washington
⁴Medical Oncology, Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
⁵Oncosalud - AUNA, Lima, Peru
⁶Department of Lymphoma and Myeloma, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Universidad Privada San Juan Bautista, Lima, Peru

Amy C.M. Musiek, MD^1*, Sean Whittaker, MD^2*, Steven M. Horwitz, MD³, Martine Bagot, MD, PhD^4*, Auris Huen, MD, PharmD^5*, David C. Fisher, MD^6*, Paul Haun, MD, MSc^7*, Maarten H. Vermeer, MD, PhD^8*, Takahiro Ito, MSc^9*, Karen Dwyer, BA^9*, Fiona Herr, PhD^10* and Youn H. Kim, MD¹¹

¹Washington University School of Medicine, St. Louis, MO
²King's College London, London, United Kingdom
³Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Hôpital Saint Louis, APHP, Inserm U976, Université de Paris, Paris, France
⁵MD Anderson Cancer Center, Houston, TX
⁶Dana Farber Cancer Institute, Boston, MA
⁷University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁸Leiden University Medical Center, Leiden, Netherlands
⁹Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ
¹⁰Kyowa Kirin, Inc., Bedminster, NJ
¹¹Stanford University, Stanford, CA

Jose Sandoval-Sus, MD¹, Franco Castillo Tokumori, MD^2*, Ning Dong, MD^2,3, Stephanie Boisclair, MD⁴, Amanda Brahim, PharmD^5*, Damaal Walker, PharmD^5*, Sanjay Bridgelall, MD^6*, Ling Zhang, MD^7*, Hayder Saeed, MD⁸ and Lubomir Sokol, MD, PhD³

¹Department of Malignant Hematology and Cellular Therapy at Memorial Healthcare System, Moffitt Cancer Center, Pembroke Pines, FL
²Department of Internal Medicine, University of South Florida, Tampa, FL
³H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Internal Medicine Residency, Memorial Healthcare System, Pembroke Pines, FL
⁵Department of Pharmacy, Memorial Hospital West, Pembroke Pines, FL
⁶Department of Hematopathology, H. Lee Moffitt Cancer Center, Tampa, FL
⁷Department of Hematopathology and Laboratory Medicine, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁸H. Lee Moffitt Cancer Center, Tampa, FL

Reghu K Sukumaran Nair, MD DCH DM PDF^1*, Vivek S Radhakrishnan, MD DM MSc PDF², Avijeet K Mishra, MBBS MD^1*, Vinay A Guntiboina, MD^2*, Saurabh J Bhave, MD PDF^2*, Jeevan Kumar Garg, MD DNB PDF^2*, Indu Arun, MD PDF^3*, Lateef Zameer, MD^3*, Debdeep Dey, MD FRCPath^3*, Neeraj Arora, MD PDF^4*, Deepak K Mishra, MD PDF^4*, Arpita Bhattacharyya, MRCP^1*, Niharendu Ghara, MD DCH FRCPath^1*, Rimpa B Achari, MD^5*, Shekhar Krishnan, MRCP FRCPath PhD^1*, Mammen Chandy, MD FRCP FRACP FRCPA² and Reena Nair, MD^2*

¹Pediatric Hematology Oncology, Tata Medical Center, Kolkata, India
²Clinical Hematology Oncology & HCT, Tata Medical Center, Kolkata, India
³Histopathology, Tata Medical Center, Kolkata, India
⁴Laboratory Hematology and Molecular Pathology, Tata Medical Center, Kolkata, India
⁵Radiation Oncology, Tata Medical Center, Kolkata, India

Samer A. Srour, MD, MS¹, Jie Xu, MD^2*, Taha Al-Juhaishi, MD³, Raphael Eric Steiner, MD⁴, Joe Ensor, PhD^5*, Sairah Ahmed, MD⁶, Simrit Parmar, M.D., MSCI⁷, Paolo Strati, MD⁸, Loretta J. Nastoupil, MD⁷, Yago Nieto, MD⁹, Chitra Hosing, MD³, Hun Ju Lee, MD⁴, Jason Westin, MD⁴, Nathan H. Fowler, MD¹⁰, Luis Fayad¹¹, Bouthaina S. Dabaja, MD^12*, Chelsea C. Pinnix, MD, PhD^13*, Jillian R. Gunther, MD, PhD^13*, Penny Fang, MD^12*, Felipe Samaniego, MD⁴, Preetesh Jain, MBBS, MD, DM, PhD⁴, Richard E. Champlin, MD³, Issa F. Khouri, MD³, Michael Wang, MD¹⁴, Roberto N. Miranda, MD^2*, Francisco Vega, MD, PhD¹⁵, Sattva S. Neelapu, MD⁴, Christopher Flowers, MD, MS¹¹ and Swami P. Iyer, MD^16,17

¹Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Hematopathology, University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Houston Methodist Cancer Center, HOUSTON, TX
⁶Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
⁷Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Department of Lymphoma and Myeloma; Department of Translational Molecular Pathology, MD Anderson Cancer Center:, Houston, TX
⁹Department of Stem Cell Transplantation and Cellular Therapy, UT M.D. Anderson Cancer Ctr., Houston, TX
¹⁰The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX
¹²Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹³Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴Department of Lymphoma and Myeloma, U.T. M.D. Anderson Cancer Center, Houston, TX
¹⁵Division of Hematopathology, Department of Pathology and Laboratory Medicine, MD Anderson Cancer Center, Houston, TX
¹⁶UT MDANDERSON, Houston, TX
¹⁷Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, SUGAR LAND, TX